Cytosorbents (CTSO) Misses Q2 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.63 million versus the consensus estimate of $9.42 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Klarna shares tumble on weak full-year revenue guidance
• SEC proposes new rules for crypto asset investment contracts